HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BAO PHARMA-B

14.900

-0.900-5.70%

Volume:561.40K

Turnover:8.48M

Market Cap:4.81B

PE:-9.38

High:15.800

Open:15.800

Low:14.900

Close:15.800

52wk High:206.000

52wk Low:14.900

Shares:323.00M

HK Float Shares:152.00M

Volume Ratio:0.98

T/O Rate:0.37%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.589

ROE:-31.30%

ROA:-10.46%

PB:2.84

PE(LYR):-9.38

PS:241.78

Loading ...

Overview Company News Filings

Bao Pharma Completes HK$1.37 Million Buyback, Treasury Shares Rise to 2.79 Million

Bulletin Express

BAO PHARMA-B (02659) Allocates HK$1.9957 Million to Buy Back 124,900 Shares on September 7

Shanghai Bao Pharma Files HKEX Next-Day Return Disclosing Share Buyback at HKD 15.98 Each

BAO PHARMA-B Repurchases 183,400 H-Shares for HKD 2.99 Million, Lifting Treasury Stock to 2.58 Million Shares

Bulletin Express

Bao Pharma-B Repurchases HK$3.99 Million in Shares, Treasury Stock Rises to 2.40 Million

Bulletin Express

Shanghai Bao Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 3.99 Million

BAO PHARMA-B (02659) Spends Approximately HK$3.99 Million on Share Buyback on September 3

Bao Pharma-B Completes HK$1.99 Million Share Buyback, Outstanding Shares Fall to 152.29 Million

Bulletin Express

Bao Pharma-B (02659) Spends HK$1.99 Million on Share Buyback on September 1

Shanghai Bao Pharma Files HKEX Next-Day Return Disclosing Share Buyback at HKD 16.73 Average Price

Bao Pharma Executes HKD 2.99 Million Share Buyback, Cuts Outstanding H-Shares by 0.12%

Bulletin Express

BAO PHARMA-B Spends HK$2.99 Million on Share Buyback on August 31st

Shanghai Bao Pharma Files HKEX Next-Day Disclosure Return After Share Buyback at HKD 16.19

Visual Guide: BAO PHARMA-B (02659) Delivers 2026 Interim Results

BAO PHARMA-B (02659) Mid-Year Results: Narrowing Losses, Solid Cash Position, and a Premium Pipeline Reinforcing Long-Term Value

Shanghai Bao Pharma H1 FY26 Loss Narrows to RMB 153.69 Million; Revenue Drops 76.5% to RMB 9.88 Million

Bao Pharmaceuticals' Trial Application for KJ015 for Injection Approved by US FDA

MT Newswires Live

BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application

Bao Pharma secures U.S. FDA IND clearance for subcutaneous HER2 bispecific antibody KJ015

Bulletin Express

Shanghai Bao Pharmaceuticals Co - U.S. FDA Approves Ind for Kj015 for Injection on August 21, 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/02659/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02659","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"BAO PHARMA-B","latestPrice":14.9,"timestamp":1789027722217,"preClose":15.8,"halted":0,"volume":561400,"delay":0,"changeRate":-0.056962025316455715,"floatShares":152000000,"shares":323000000,"eps":-1.5886164148324722,"marketStatus":"Closed","change":-0.9,"latestTime":"09-10 16:08:42","open":15.8,"high":15.8,"low":14.9,"amount":8480940,"amplitude":0.056962,"askPrice":15.02,"askSize":1500,"bidPrice":14.9,"bidSize":19900,"shortable":0,"etf":0,"ttmEps":-1.3822364529408535,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":15.8,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.978697,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","floatShares":152000000,"roa":"-10.46%","roe":"-31.30%","lyrEps":-1.588616,"volumeRatio":0.978697,"shares":323000000,"dividePrice":0,"high":15.8,"amplitude":0.056962,"preClose":15.8,"low":14.9,"week52Low":14.9,"pbRate":"2.84","psRate":"241.78","week52High":206,"institutionHeld":0,"latestPrice":14.9,"committee":0.859813,"eps":-1.5886164148324722,"divideRate":0,"volume":561400,"delay":0,"ttmEps":-1.3822364529408535,"open":15.8,"prevYearClose":77.55,"prevWeekClose":16.06,"prevMonthClose":16.44,"prevQuarterClose":18,"fiveDayClose":16.43,"twentyDayClose":17.07,"sixtyDayClose":18.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02659\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02659","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-26","symbol":"02659","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02659\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02659\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1779984000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02659\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02659","date":"2026-09-09","current":-10.883453,"percent":0.912088,"low":-150.791275,"twenty":-74.902076,"median":-49.027166,"eighty":-12.705803,"high":-11.128507,"avg":-45.865517,"sd":35.75087,"marketCap":5149002987},"quantilePoints":[{"date":"2025-12-12","current":-53.146224,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"marketCap":22280833132},{"date":"2025-12-19","current":-56.628418,"twenty":-56.115318,"median":-53.146224,"eighty":-50.330094,"marketCap":23796646945},{"date":"2025-12-24","current":-60.667186,"twenty":-57.368285,"median":-54.841733,"eighty":-51.357726,"marketCap":25573245929},{"date":"2026-01-02","current":-53.689307,"twenty":-58.867149,"median":-56.13619,"eighty":-51.993778,"marketCap":22720908110},{"date":"2026-01-09","current":-60.663453,"twenty":-59.744205,"median":-56.240552,"eighty":-53.146224,"marketCap":25736236661},{"date":"2026-01-16","current":-77.814349,"twenty":-61.547088,"median":-57.565784,"eighty":-53.651638,"marketCap":33119716844},{"date":"2026-01-23","current":-76.125836,"twenty":-72.759479,"median":-58.867149,"eighty":-53.689307,"marketCap":32369959474},{"date":"2026-01-30","current":-79.366151,"twenty":-76.125836,"median":-60.665319,"eighty":-55.0155,"marketCap":33902072360},{"date":"2026-02-06","current":-84.493791,"twenty":-76.125836,"median":-61.547088,"eighty":-55.626475,"marketCap":36183942615},{"date":"2026-02-13","current":-126.016863,"twenty":-78.017279,"median":-67.830536,"eighty":-56.031828,"marketCap":54275913922},{"date":"2026-02-20","current":-138.174242,"twenty":-79.686668,"median":-71.167377,"eighty":-56.115318,"marketCap":59426421069},{"date":"2026-02-27","current":-116.132786,"twenty":-104.714701,"median":-73.426035,"eighty":-56.395698,"marketCap":50494528928},{"date":"2026-03-06","current":-76.640212,"twenty":-111.983375,"median":-74.892856,"eighty":-56.998352,"marketCap":33054520551},{"date":"2026-03-13","current":-75.987902,"twenty":-110.582832,"median":-75.36732,"eighty":-57.563278,"marketCap":32924127965},{"date":"2026-03-20","current":-70.725897,"twenty":-109.509649,"median":-74.892856,"eighty":-57.733099,"marketCap":30528164197},{"date":"2026-03-27","current":-65.400661,"twenty":-104.714701,"median":-74.674242,"eighty":-58.326024,"marketCap":29273135557},{"date":"2026-04-02","current":-74.510382,"twenty":-96.653813,"median":-73.605533,"eighty":-59.04256,"marketCap":33510894602},{"date":"2026-04-10","current":-71.602503,"twenty":-91.308972,"median":-74.057958,"eighty":-59.568794,"marketCap":32451454840},{"date":"2026-04-17","current":-64.454748,"twenty":-86.399914,"median":-73.087213,"eighty":-60.479603,"marketCap":29224238337},{"date":"2026-04-24","current":-55.967849,"twenty":-84.718643,"median":-71.1642,"eighty":-60.173931,"marketCap":25377657050},{"date":"2026-04-30","current":-18.543355,"twenty":-83.426575,"median":-70.300184,"eighty":-58.506399,"marketCap":8410321797},{"date":"2026-05-08","current":-19.625214,"twenty":-81.092081,"median":-69.74185,"eighty":-56.760202,"marketCap":8931892141},{"date":"2026-05-15","current":-17.930681,"twenty":-79.944236,"median":-68.961959,"eighty":-55.831299,"marketCap":8182134771},{"date":"2026-05-22","current":-17.55647,"twenty":-79.579829,"median":-66.237091,"eighty":-53.674239,"marketCap":7993065521},{"date":"2026-05-29","current":-17.509903,"twenty":-78.962132,"median":-66.085797,"eighty":-51.516739,"marketCap":7999585151},{"date":"2026-06-05","current":-15.389804,"twenty":-78.220574,"median":-65.202887,"eighty":-19.743808,"marketCap":7041199644},{"date":"2026-06-12","current":-13.774642,"twenty":-77.936107,"median":-64.592987,"eighty":-19.178821,"marketCap":6297961903},{"date":"2026-06-18","current":-12.785133,"twenty":-77.726882,"median":-64.454748,"eighty":-18.7468,"marketCap":5857886926},{"date":"2026-06-26","current":-11.736313,"twenty":-77.358698,"median":-62.675612,"eighty":-18.25553,"marketCap":5352615655},{"date":"2026-07-03","current":-13.348826,"twenty":-77.285436,"median":-61.290684,"eighty":-17.828553,"marketCap":6092593580},{"date":"2026-07-10","current":-14.187594,"twenty":-77.122448,"median":-60.663453,"eighty":-17.509903,"marketCap":6467472265},{"date":"2026-07-17","current":-12.348746,"twenty":-76.777398,"median":-59.36056,"eighty":-15.389804,"marketCap":5649258788},{"date":"2026-07-24","current":-12.28898,"twenty":-76.640212,"median":-57.965274,"eighty":-14.102609,"marketCap":5623180271},{"date":"2026-07-31","current":-12.265678,"twenty":-76.228711,"median":-57.553252,"eighty":-13.925373,"marketCap":5623180271},{"date":"2026-08-07","current":-12.759971,"twenty":-76.015489,"median":-56.434485,"eighty":-13.758151,"marketCap":5861146740},{"date":"2026-08-14","current":-11.978357,"twenty":-75.491436,"median":-55.967849,"eighty":-13.50755,"marketCap":5509086758},{"date":"2026-08-21","current":-11.379099,"twenty":-75.31975,"median":-54.455852,"eighty":-13.139203,"marketCap":5245041771},{"date":"2026-08-28","current":-11.185615,"twenty":-75.047246,"median":-53.651638,"eighty":-12.841314,"marketCap":5157026776},{"date":"2026-09-04","current":-12.259564,"twenty":-74.97059,"median":-51.596245,"eighty":-12.752538,"marketCap":5233733415},{"date":"2026-09-09","current":-12.041818,"twenty":-74.902076,"median":-49.027166,"eighty":-12.705803,"marketCap":5149002987}],"updateTime":1789023402377},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02659\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133093859","title":"Bao Pharma Completes HK$1.37 Million Buyback, Treasury Shares Rise to 2.79 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1133093859","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133093859?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:03","pubTimestamp":1788861804,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) repurchased 85,800 H-shares on 08 September 2026 via on-market transactions, paying a total of HK$1.37 million at prices ranging from HK$15.81 to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124774824","title":"BAO PHARMA-B (02659) Allocates HK$1.9957 Million to Buy Back 124,900 Shares on September 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1124774824","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124774824?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:56","pubTimestamp":1788774976,"startTime":"0","endTime":"0","summary":"On September 7, 2026, BAO PHARMA-B (02659) executed a share repurchase, spending approximately HK$1.9957 million to buy back 124,900 of its own shares.The company disclosed that the buyback was...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665720313","title":"Shanghai Bao Pharma Files HKEX Next-Day Return Disclosing Share Buyback at HKD 15.98 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2665720313","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665720313?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:47","pubTimestamp":1788774430,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day return disclosing share buyback at HKD 15.98 eachShanghai Bao Pharmaceuticals repurchased 124,900 H shares on Sept. 7, holding them as treasury shares; no share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL3t0J9w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159388329","title":"BAO PHARMA-B Repurchases 183,400 H-Shares for HKD 2.99 Million, Lifting Treasury Stock to 2.58 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1159388329","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159388329?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:22","pubTimestamp":1788517321,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (trading as BAO PHARMA-B) disclosed that it repurchased 183,400 H-shares on the Hong Kong Stock Exchange on 4 September 2026. The on-market transactions were...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158121017","title":"Bao Pharma-B Repurchases HK$3.99 Million in Shares, Treasury Stock Rises to 2.40 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1158121017","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158121017?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:22","pubTimestamp":1788438178,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma-B) disclosed a share buyback of 240,900 H-shares on 3 September 2026. The repurchase, executed on the Hong Kong Stock Exchange under the existing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871031","title":"Shanghai Bao Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 3.99 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871031","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871031?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:05","pubTimestamp":1788437130,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day return disclosing share repurchase at HKD 3.99 millionShanghai Bao Pharmaceuticals repurchased 240,900 H shares on Sept. 3, 2026 for treasury.Paid HKD 16.15–HKD 17.12 a share; aggregate consideration HKD 3,991,416.Cancelled shares: 0.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on September 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL7nJfvB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165605785","title":"BAO PHARMA-B (02659) Spends Approximately HK$3.99 Million on Share Buyback on September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1165605785","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165605785?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:04","pubTimestamp":1788437052,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on September 3, 2026, it expended roughly HK$3.9914 million to repurchase 240,900 of its own shares.This buyback activity reflects the company's ongoing capital management strategy, utilizing available funds to consolidate its equity base in the open market.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100111680","title":"Bao Pharma-B Completes HK$1.99 Million Share Buyback, Outstanding Shares Fall to 152.29 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1100111680","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100111680?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:21","pubTimestamp":1788258102,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma-B) disclosed that it repurchased 119,200 H-shares on 1 September 2026 via on-exchange transactions, paying an aggregate HK$1.99 million. The shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111178056","title":"Bao Pharma-B (02659) Spends HK$1.99 Million on Share Buyback on September 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1111178056","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111178056?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:12","pubTimestamp":1788257538,"startTime":"0","endTime":"0","summary":"Shanghai, September 1 (AFN) - BAO PHARMA-B (02659) announced that it repurchased 119,200 shares on September 1, 2026, at a total cost of HK$1.9942 million.The buyback price per share ranged between HK$16.48 and HK$16.81.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830794","title":"Shanghai Bao Pharma Files HKEX Next-Day Return Disclosing Share Buyback at HKD 16.73 Average Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830794","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830794?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:04","pubTimestamp":1788257047,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day return disclosing share buyback at HKD 16.73 average priceShanghai Bao Pharmaceuticals repurchased 119,200 H shares on Sept. 1, holding them as treasury shares.Buyback price range HKD 16.48 to HKD 16.81 per share; total consideration HKD 1.99 million.Cancelled shares: 0.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on September 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL81X2R1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160752824","title":"Bao Pharma Executes HKD 2.99 Million Share Buyback, Cuts Outstanding H-Shares by 0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160752824","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160752824?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:21","pubTimestamp":1788171702,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma; 02659.HK) reported a share repurchase on 31 August 2026 under its Hong Kong Stock Exchange (HKEX) mandate: the company bought back 184,800 H-shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195143069","title":"BAO PHARMA-B Spends HK$2.99 Million on Share Buyback on August 31st","url":"https://stock-news.laohu8.com/highlight/detail?id=1195143069","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195143069?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:03","pubTimestamp":1788170595,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) announced that it repurchased 184,800 shares on August 31, 2026, for a total consideration of approximately HK$2.9912 million.The buyback was executed at a per-share price ranging from HK$15.69 to HK$16.66.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663807157","title":"Shanghai Bao Pharma Files HKEX Next-Day Disclosure Return After Share Buyback at HKD 16.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2663807157","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663807157?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:57","pubTimestamp":1788170235,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day disclosure return after share buyback at HKD 16.19Shanghai Bao Pharmaceuticals repurchased 184,800 H shares on Aug. 31, 2026 for treasury.Buyback executed on HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL7wD6rw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134924940","title":"Visual Guide: BAO PHARMA-B (02659) Delivers 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1134924940","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134924940?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:32","pubTimestamp":1787913125,"startTime":"0","endTime":"0","summary":"A clear infographic breakdown of BAO PHARMA-B (02659) 2026 interim results is now available, highlighting key financial metrics and operational milestones for the period under review.The visual...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129257013","title":"BAO PHARMA-B (02659) Mid-Year Results: Narrowing Losses, Solid Cash Position, and a Premium Pipeline Reinforcing Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1129257013","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129257013?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:12","pubTimestamp":1787911954,"startTime":"0","endTime":"0","summary":"On August 28, BAO PHARMA-B (02659) released its interim results for the first half of 2026, posting a notable improvement in operational quality. The company's net loss narrowed significantly to RMB...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662582069","title":"Shanghai Bao Pharma H1 FY26 Loss Narrows to RMB 153.69 Million; Revenue Drops 76.5% to RMB 9.88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662582069","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662582069?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:01","pubTimestamp":1787911300,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma H1 FY26 loss narrows to RMB 153.69 million; revenue drops 76.5% to RMB 9.88 millionShanghai Bao Pharmaceuticals posted a net loss of RMB 153.69 million, narrowing from RMB 183.1 mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLb4s9jW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661627930","title":"Bao Pharmaceuticals' Trial Application for KJ015 for Injection Approved by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2661627930","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661627930?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575215,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals'  investigational new drug application for the clinical trials of KJ015 for injection was approved by the U.S. Food and Drug Administration.The injection is a subcutaneous formulation of dual epitope-targeting HER2 bispecific antibody, according to a Monday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK1161","LABU","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181313648","title":"BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1181313648","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181313648?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566138,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on August 21, 2026, its independently developed KJ015 injection, a subcutaneous formulation of a bispecific antibody targeting HER2, received Investigational...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IBBJ","BK4585","02659","BK4588","BMED","MDTX","BK1161","PSYK","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101074301","title":"Bao Pharma secures U.S. FDA IND clearance for subcutaneous HER2 bispecific antibody KJ015","url":"https://stock-news.laohu8.com/highlight/detail?id=1101074301","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101074301?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:06","pubTimestamp":1787565960,"startTime":"0","endTime":"0","summary":"On 21 August 2026, Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) received U.S. Food and Drug Administration clearance for an Investigational New Drug application covering KJ015 for Injection...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272972","title":"Shanghai Bao Pharmaceuticals Co - U.S. FDA Approves Ind for Kj015 for Injection on August 21, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661272972?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:00","pubTimestamp":1787565636,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44J058:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":131,"code":"91000000","status":"200"}]}}